Annual Accounts Receivable
$20.73 M
+$9.88 M+91.02%
December 31, 2023
Summary
- As of February 7, 2025, XTNT annual accounts receivable is $20.73 million, with the most recent change of +$9.88 million (+91.02%) on December 31, 2023.
- During the last 3 years, XTNT annual accounts receivable has risen by +$13.85 million (+201.32%).
- XTNT annual accounts receivable is now at all-time high.
Performance
XTNT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$20.55 M
-$642.00 K-3.03%
September 30, 2024
Summary
- As of February 7, 2025, XTNT quarterly accounts receivable is $20.55 million, with the most recent change of -$642.00 thousand (-3.03%) on September 30, 2024.
- Over the past year, XTNT quarterly accounts receivable has increased by +$1.40 million (+7.28%).
- XTNT quarterly accounts receivable is now -4.37% below its all-time high of $21.48 million, reached on March 31, 2024.
Performance
XTNT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
XTNT Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +91.0% | +7.3% |
| 3 y3 years | +201.3% | +225.0% |
| 5 y5 years | +107.5% | +125.3% |
XTNT Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +189.8% | -4.4% | +187.2% |
| 5 y | 5-year | at high | +201.3% | -4.4% | +225.0% |
| alltime | all time | at high | >+9999.0% | -4.4% | >+9999.0% |
Xtant Medical Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $20.55 M(-3.0%) |
| Jun 2024 | - | $21.19 M(-1.4%) |
| Mar 2024 | - | $21.48 M(+3.6%) |
| Dec 2023 | $20.73 M(+91.0%) | $20.73 M(+8.3%) |
| Sep 2023 | - | $19.15 M(+39.3%) |
| Jun 2023 | - | $13.74 M(+15.5%) |
| Mar 2023 | - | $11.90 M(+9.7%) |
| Dec 2022 | $10.85 M(+51.7%) | $10.85 M(+10.3%) |
| Sep 2022 | - | $9.84 M(+14.4%) |
| Jun 2022 | - | $8.60 M(+14.0%) |
| Mar 2022 | - | $7.54 M(+5.5%) |
| Dec 2021 | $7.15 M(+4.0%) | $7.15 M(+13.2%) |
| Sep 2021 | - | $6.32 M(-9.5%) |
| Jun 2021 | - | $6.99 M(-0.6%) |
| Mar 2021 | - | $7.03 M(+2.1%) |
| Dec 2020 | $6.88 M(-32.0%) | $6.88 M(-6.0%) |
| Sep 2020 | - | $7.32 M(-3.5%) |
| Jun 2020 | - | $7.58 M(-22.2%) |
| Mar 2020 | - | $9.74 M(-3.8%) |
| Dec 2019 | $10.12 M(+1.3%) | $10.12 M(+11.0%) |
| Sep 2019 | - | $9.12 M(+6.5%) |
| Jun 2019 | - | $8.56 M(-9.8%) |
| Mar 2019 | - | $9.49 M(-5.0%) |
| Dec 2018 | $9.99 M(-21.4%) | $9.99 M(+1.2%) |
| Sep 2018 | - | $9.87 M(-5.1%) |
| Jun 2018 | - | $10.40 M(+0.6%) |
| Mar 2018 | - | $10.34 M(-18.7%) |
| Dec 2017 | $12.71 M(-33.1%) | $12.71 M(-8.6%) |
| Sep 2017 | - | $13.91 M(-12.2%) |
| Jun 2017 | - | $15.85 M(-2.9%) |
| Mar 2017 | - | $16.32 M(-14.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | $18.99 M(+23.4%) | $18.99 M(+20.0%) |
| Sep 2016 | - | $15.83 M(+7.5%) |
| Jun 2016 | - | $14.72 M(-1.3%) |
| Mar 2016 | - | $14.92 M(-3.0%) |
| Dec 2015 | $15.39 M(+247.5%) | $15.39 M(+15.5%) |
| Sep 2015 | - | $13.32 M(+138.9%) |
| Jun 2015 | - | $5.57 M(+1.4%) |
| Mar 2015 | - | $5.50 M(+24.1%) |
| Dec 2014 | $4.43 M(-7.6%) | $4.43 M(+3.1%) |
| Sep 2014 | - | $4.29 M(-12.3%) |
| Jun 2014 | - | $4.90 M(-11.4%) |
| Mar 2014 | - | $5.53 M(+15.3%) |
| Dec 2013 | $4.79 M(-33.0%) | $4.79 M(+3.5%) |
| Sep 2013 | - | $4.63 M(-25.6%) |
| Jun 2013 | - | $6.23 M(-13.1%) |
| Mar 2013 | - | $7.16 M(+0.1%) |
| Dec 2012 | $7.15 M(+1.0%) | $7.15 M(-0.4%) |
| Sep 2012 | - | $7.18 M(+9.1%) |
| Jun 2012 | - | $6.58 M(-13.4%) |
| Mar 2012 | - | $7.60 M(+7.3%) |
| Dec 2011 | $7.08 M(+101.1%) | $7.08 M(+10.2%) |
| Sep 2011 | - | $6.43 M(+17.0%) |
| Jun 2011 | - | $5.49 M(+12.3%) |
| Mar 2011 | - | $4.89 M(+38.9%) |
| Dec 2010 | $3.52 M(+122.2%) | $3.52 M(+37.5%) |
| Sep 2010 | - | $2.56 M(+31.4%) |
| Jun 2010 | - | $1.95 M(>+9900.0%) |
| Mar 2010 | - | $5600.00(-99.6%) |
| Dec 2009 | $1.58 M(+2563.9%) | $1.58 M(+8028.2%) |
| Sep 2009 | - | $19.50 K(-67.2%) |
| Dec 2008 | $59.50 K | $59.50 K |
FAQ
- What is Xtant Medical Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Xtant Medical Holdings?
- What is Xtant Medical Holdings annual accounts receivable year-on-year change?
- What is Xtant Medical Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Xtant Medical Holdings?
- What is Xtant Medical Holdings quarterly accounts receivable year-on-year change?
What is Xtant Medical Holdings annual accounts receivable?
The current annual accounts receivable of XTNT is $20.73 M
What is the all time high annual accounts receivable for Xtant Medical Holdings?
Xtant Medical Holdings all-time high annual accounts receivable is $20.73 M
What is Xtant Medical Holdings annual accounts receivable year-on-year change?
Over the past year, XTNT annual accounts receivable has changed by +$9.88 M (+91.02%)
What is Xtant Medical Holdings quarterly accounts receivable?
The current quarterly accounts receivable of XTNT is $20.55 M
What is the all time high quarterly accounts receivable for Xtant Medical Holdings?
Xtant Medical Holdings all-time high quarterly accounts receivable is $21.48 M
What is Xtant Medical Holdings quarterly accounts receivable year-on-year change?
Over the past year, XTNT quarterly accounts receivable has changed by +$1.40 M (+7.28%)